[Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].
Treatment-resistant hypertension is still common despite the availability of several types of antihypertensive agents acting by different mechanisms. The existence of refractory hypertension should lead to rule out "white-coat hypertension", poor adherence to prescribed drugs as well as classical causes of secondary hypertension such as renal artery stenosis, primary aldosteronism, pheochromocytoma and renal disease. It is also important to consider the possible existence of obstructive sleep apnea or the regular intake of vasopressive drugs or substances.
Division de physiopathologie clinique, CHUV, 1011 Lausanne. Bernard.Waeber@chuv.ch
B
B
Waeber
F
F
Feihl
D000310:Adrenal Gland Neoplasms / Q000150:complications; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D018660:Blood Pressure Monitoring, Ambulatory; D015897:Comorbidity; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D007674:Kidney Diseases / Q000150:complications; D055118:Medication Adherence; D010673:Pheochromocytoma / Q000150:complications; D012078:Renal Artery Obstruction / Q000150:complications; D012307:Risk Factors; D020181:Sleep Apnea, Obstructive / Q000150:complications* / Q000188:drug therapy; D014662:Vasoconstrictor Agents / Q000009:adverse effects; D059466:White Coat Hypertension / Q000175:diagnosis
D000959:Antihypertensive Agents; D014662:Vasoconstrictor Agents